Outbreaks of filovirus hemorrhagic fever

Time to refocus on the patient

Daniel G. Bausch, Heinz Feldmann, Thomas Geisbert, Mike Bray, A. G. Sprecher, Paul Boumandouki, Pierre E. Rollin, Cathy Roth

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

In the 40 years since the recognition of filoviruses as agents of lethal human disease, there have been no specific advances in antiviral therapies or vaccines and few clinical studies on the efficacy of supportive care. On 20 September 2006, experts from 14 countries representing 68 institutions integrally involved in the response to outbreaks of filovirus hemorrhagic fever gathered at the National Microbiology Laboratory of the Public Health Agency of Canada in Winnipeg to discuss possible remedies for this grim situation, in a unique workshop entitled "Marburg and Ebola Hemorrhagic Fever: Feasibility of Prophylaxis and Therapy." A summary of the opportunities for and challenges to improving treatment of filovirus hemorrhagic fevers is presented here.

Original languageEnglish (US)
JournalJournal of Infectious Diseases
Volume196
Issue numberSUPPL. 2
DOIs
StatePublished - Nov 15 2007
Externally publishedYes

Fingerprint

Disease Outbreaks
Marburg Virus Disease
Ebola Hemorrhagic Fever
Fever
Active Immunotherapy
Microbiology
Canada
Antiviral Agents
Public Health
Education
Therapeutics
Clinical Studies

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Bausch, D. G., Feldmann, H., Geisbert, T., Bray, M., Sprecher, A. G., Boumandouki, P., ... Roth, C. (2007). Outbreaks of filovirus hemorrhagic fever: Time to refocus on the patient. Journal of Infectious Diseases, 196(SUPPL. 2). https://doi.org/10.1086/520542

Outbreaks of filovirus hemorrhagic fever : Time to refocus on the patient. / Bausch, Daniel G.; Feldmann, Heinz; Geisbert, Thomas; Bray, Mike; Sprecher, A. G.; Boumandouki, Paul; Rollin, Pierre E.; Roth, Cathy.

In: Journal of Infectious Diseases, Vol. 196, No. SUPPL. 2, 15.11.2007.

Research output: Contribution to journalArticle

Bausch, DG, Feldmann, H, Geisbert, T, Bray, M, Sprecher, AG, Boumandouki, P, Rollin, PE & Roth, C 2007, 'Outbreaks of filovirus hemorrhagic fever: Time to refocus on the patient', Journal of Infectious Diseases, vol. 196, no. SUPPL. 2. https://doi.org/10.1086/520542
Bausch DG, Feldmann H, Geisbert T, Bray M, Sprecher AG, Boumandouki P et al. Outbreaks of filovirus hemorrhagic fever: Time to refocus on the patient. Journal of Infectious Diseases. 2007 Nov 15;196(SUPPL. 2). https://doi.org/10.1086/520542
Bausch, Daniel G. ; Feldmann, Heinz ; Geisbert, Thomas ; Bray, Mike ; Sprecher, A. G. ; Boumandouki, Paul ; Rollin, Pierre E. ; Roth, Cathy. / Outbreaks of filovirus hemorrhagic fever : Time to refocus on the patient. In: Journal of Infectious Diseases. 2007 ; Vol. 196, No. SUPPL. 2.
@article{0e0187ff3d3a4e278bad0c2a8466026b,
title = "Outbreaks of filovirus hemorrhagic fever: Time to refocus on the patient",
abstract = "In the 40 years since the recognition of filoviruses as agents of lethal human disease, there have been no specific advances in antiviral therapies or vaccines and few clinical studies on the efficacy of supportive care. On 20 September 2006, experts from 14 countries representing 68 institutions integrally involved in the response to outbreaks of filovirus hemorrhagic fever gathered at the National Microbiology Laboratory of the Public Health Agency of Canada in Winnipeg to discuss possible remedies for this grim situation, in a unique workshop entitled {"}Marburg and Ebola Hemorrhagic Fever: Feasibility of Prophylaxis and Therapy.{"} A summary of the opportunities for and challenges to improving treatment of filovirus hemorrhagic fevers is presented here.",
author = "Bausch, {Daniel G.} and Heinz Feldmann and Thomas Geisbert and Mike Bray and Sprecher, {A. G.} and Paul Boumandouki and Rollin, {Pierre E.} and Cathy Roth",
year = "2007",
month = "11",
day = "15",
doi = "10.1086/520542",
language = "English (US)",
volume = "196",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Outbreaks of filovirus hemorrhagic fever

T2 - Time to refocus on the patient

AU - Bausch, Daniel G.

AU - Feldmann, Heinz

AU - Geisbert, Thomas

AU - Bray, Mike

AU - Sprecher, A. G.

AU - Boumandouki, Paul

AU - Rollin, Pierre E.

AU - Roth, Cathy

PY - 2007/11/15

Y1 - 2007/11/15

N2 - In the 40 years since the recognition of filoviruses as agents of lethal human disease, there have been no specific advances in antiviral therapies or vaccines and few clinical studies on the efficacy of supportive care. On 20 September 2006, experts from 14 countries representing 68 institutions integrally involved in the response to outbreaks of filovirus hemorrhagic fever gathered at the National Microbiology Laboratory of the Public Health Agency of Canada in Winnipeg to discuss possible remedies for this grim situation, in a unique workshop entitled "Marburg and Ebola Hemorrhagic Fever: Feasibility of Prophylaxis and Therapy." A summary of the opportunities for and challenges to improving treatment of filovirus hemorrhagic fevers is presented here.

AB - In the 40 years since the recognition of filoviruses as agents of lethal human disease, there have been no specific advances in antiviral therapies or vaccines and few clinical studies on the efficacy of supportive care. On 20 September 2006, experts from 14 countries representing 68 institutions integrally involved in the response to outbreaks of filovirus hemorrhagic fever gathered at the National Microbiology Laboratory of the Public Health Agency of Canada in Winnipeg to discuss possible remedies for this grim situation, in a unique workshop entitled "Marburg and Ebola Hemorrhagic Fever: Feasibility of Prophylaxis and Therapy." A summary of the opportunities for and challenges to improving treatment of filovirus hemorrhagic fevers is presented here.

UR - http://www.scopus.com/inward/record.url?scp=38449108229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38449108229&partnerID=8YFLogxK

U2 - 10.1086/520542

DO - 10.1086/520542

M3 - Article

VL - 196

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - SUPPL. 2

ER -